Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002411.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Bad
0%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -1.13 0.75 0.76
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -411.06 -10.15 -1.99
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.80 3.67 3.61
Cash -38.08 0.37 0.59
Capex 96.39 -0.03 -0.84
Free Cash Flow 92.00 -0.14 -1.74
Revenue -34.64 0.79 1.21
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -56.23 0.07 0.16
Operating Margin 85.02 -0.13 -0.87
ROA 88.45 -0.01 -0.10
ROE 88.08 -0.03 -0.25
ROIC 85.43 -0.02 -0.15
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002411.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002411.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002411.SZ is permitted for members.